financetom
Business
financetom
/
Business
/
TCS welcomes new CEO and MD – K Krithivasan: A look at the road ahead
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TCS welcomes new CEO and MD – K Krithivasan: A look at the road ahead
May 31, 2023 11:55 PM

Tata Consultancy Services (TCS) on June 1 welcomed its new CEO and MD — K Krithivasan, the company’s fifth CEO since it was set up in 1968. The fact the IT giant has had only five CEOs in its 55 years of history shows it is a stable ship and is a testimony to the stability and quality of its management.

Share Market Live

NSE

Krithivasan will be succeeding Rajesh Gopinathan (2017–2023).

K Krithivasan is a TCS veteran — one could call him a lifer just like his predecessors. He joined in 1989 and has been with the company for the last 34 years.

During his long tenure at TCS, he has held various leadership roles in delivery, customer relationship management, large programme management and sales. Prior to his elevation as CEO and MD, Krithivasan was the President and Global Head of the BFSI vertical, which contributes 32 percent to the firm’s revenue.

Krithi holds a bachelor’s degree in Mechanical Engineering from the University of Madras and a master’s degree in Industrial and Management Engineering from IIT Kanpur.

The question that now arises is — Does the change of guard mean a strategy change?

In the fourth quarter earnings call, Krithi said, “Leadership change doesn't mean a strategy change. All of us have been working with this organisation for so many years and all of us have a good understanding. Whatever strategy Rajesh put in place was also a collective leadership decision on how we want to go forward. So I don't expect a drastic strategy change. We'll be tweaking what we do based on the market situation.”

The key ask from new TCS CEO Krithivasan?

It seems the key expectation from him may be to make TCS grow faster than its peers. While there is no doubt, under Gopinathan as CEO, TCS delivered a strong financial performance, with revenue growth of 11.5 percent and constant currency revenue growth of 8.8 percent over the last six years, but its peer Infosys has grown even faster than TCS over the last four years even TCS maintained its margin supremacy.

Infosys growth beats TCS for the 4th straight year

CC Rev growthFY18FY19FY20FY21FY22FY23
Infosys5.8%9.0%9.8%5.0%19.7%15.40%
TCS6.70%11.40%7.10%-0.80%15.40%13.7%

Track latest stock market updates on CNBCTV18.com's blog

First Published:Jun 1, 2023 8:55 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Apple's iPhone Sales in China Soar 52% in April
Market Chatter: Apple's iPhone Sales in China Soar 52% in April
May 28, 2024
06:33 AM EDT, 05/28/2024 (MT Newswires) -- Apple's ( AAPL ) smartphone shipments in China rose 52% in April compared with a year earlier, Reuters reported Tuesday, citing data from a research firm affiliated with the Chinese government. Shipments of foreign-branded phones in China increased last month to 3.495 million units from 2.301 million a year earlier, the report said....
Bank of Nova Scotia Fiscal Q2 Earnings Fall, Revenue Increases
Bank of Nova Scotia Fiscal Q2 Earnings Fall, Revenue Increases
May 28, 2024
06:39 AM EDT, 05/28/2024 (MT Newswires) -- Bank of Nova Scotia ( BNS ) (BNS) reported fiscal Q2 adjusted earnings Tuesday of CA$1.58 ($1.16) per diluted share, down from CA$1.69 a year earlier. Analysts polled by Capital IQ expected CA$1.56. Revenue for the quarter ended April 30 expressed as the sum of net interest income and total noninterest income was...
Calliditas Therapeutics' Board Urges Shareholders to Embrace $1.06 Billion Buyout Offer
Calliditas Therapeutics' Board Urges Shareholders to Embrace $1.06 Billion Buyout Offer
May 28, 2024
06:36 AM EDT, 05/28/2024 (MT Newswires) -- Calliditas Therapeutics ( CALT ) said Tuesday its board of directors unanimously recommended that its shareholders accept an 11.16 billion Swedish krona ($1.06 billion) cash buyout offer from Asahi Kasei. Following the news, Calliditas shares were up more than 75% in recent Tuesday premarket activity The Japanese pharmaceutical company is offering 208 Swedish...
Brazil's Inter&Co buys out partner BMG in payment firm Granito
Brazil's Inter&Co buys out partner BMG in payment firm Granito
May 28, 2024
SAO PAULO, May 28 (Reuters) - Brazilian digital bank Inter&Co has signed a deal to become payment firm Granito's sole shareholder, it said on Tuesday, buying out fellow lender BMG in a 110 million reais ($21.26 million) deal. Inter&Co, which already owned a 50% stake in Granito, said in a securities filing it had bought the remaining 50% from BMG....
Copyright 2023-2026 - www.financetom.com All Rights Reserved